One data point makes new results on Pfizer's cancer drug Lorbrena quite eye-catching: It reduced disease progression by 81%.
Comments
(゚д゚)
There's nothing here…
One data point makes new results on Pfizer's cancer drug Lorbrena quite eye-catching: It reduced disease progression by 81%.